Coloplast A/S (CBHD) Ratios
Coloplast A/S Ratios
CH:CBHD's free cash flow for Q3 2026 was $1.45B. For the 2026 fiscal year, CH:CBHD's free cash flow was decreased by $-260.00M and operating cash flow was $1.71B. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.61 | 1.02 | 0.61 | 1.20 | 1.11 |
| Quick Ratio | 1.00 | 0.66 | 0.39 | 0.76 | 0.72 |
| Cash Ratio | 0.15 | 0.08 | 0.06 | 0.06 | 0.07 |
| Solvency Ratio | 0.15 | 0.21 | 0.19 | 0.21 | 0.73 |
| Operating Cash Flow Ratio | 1.02 | 0.27 | 0.26 | 0.70 | 0.84 |
| Short-Term Operating Cash Flow Coverage | 2.57 | 0.54 | 0.59 | 3.10 | 2.45 |
| Net Current Asset Value | $ -21.79B | $ -19.69B | $ -20.92B | $ -17.89B | $ -679.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.47 | 0.47 | 0.41 | 0.54 | 0.18 |
| Debt-to-Equity Ratio | 1.40 | 1.26 | 1.13 | 2.26 | 0.34 |
| Debt-to-Capital Ratio | 0.58 | 0.56 | 0.53 | 0.69 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.55 | 0.48 | 0.40 | 0.66 | 0.00 |
| Financial Leverage Ratio | 3.00 | 2.68 | 2.78 | 4.22 | 1.94 |
| Debt Service Coverage Ratio | 1.70 | 1.21 | 0.83 | 3.08 | 2.56 |
| Interest Coverage Ratio | 9.19 | 8.30 | 9.42 | 26.83 | 111.49 |
| Debt to Market Cap | 0.18 | 0.11 | 0.12 | 0.11 | 0.01 |
| Interest Debt Per Share | 104.11 | 104.54 | 94.18 | 89.17 | 13.36 |
| Net Debt to EBITDA | 2.60 | 2.55 | 2.41 | 2.53 | 0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.06% | 67.59% | 66.64% | 68.78% | 68.53% |
| EBIT Margin | 25.05% | 27.04% | 27.20% | 27.90% | 32.21% |
| EBITDA Margin | 29.91% | 31.69% | 31.56% | 32.02% | 36.46% |
| Operating Profit Margin | 27.19% | 27.08% | 27.64% | 28.52% | 32.71% |
| Pretax Profit Margin | 22.09% | 23.66% | 24.59% | 27.14% | 32.09% |
| Net Profit Margin | 13.04% | 18.69% | 19.52% | 20.84% | 24.84% |
| Continuous Operations Profit Margin | 13.04% | 18.69% | 19.52% | 20.84% | 24.84% |
| Net Income Per EBT | 59.05% | 79.00% | 79.39% | 76.81% | 77.41% |
| EBT Per EBIT | 81.24% | 87.36% | 88.98% | 95.15% | 98.08% |
| Return on Assets (ROA) | 7.52% | 10.51% | 9.93% | 13.46% | 30.46% |
| Return on Equity (ROE) | 22.55% | 28.16% | 27.65% | 56.75% | 59.07% |
| Return on Capital Employed (ROCE) | 18.10% | 19.33% | 21.26% | 23.31% | 66.71% |
| Return on Invested Capital (ROIC) | 10.07% | 13.38% | 13.71% | 16.78% | 41.47% |
| Return on Tangible Assets | 19.59% | 28.48% | 28.30% | 32.06% | 39.58% |
| Earnings Yield | 2.97% | 2.57% | 2.97% | 2.85% | 2.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.39 | 5.36 | 5.34 | 5.22 | 5.65 |
| Payables Turnover | 7.35 | 5.77 | 6.32 | 5.68 | 5.90 |
| Inventory Turnover | 2.48 | 2.39 | 2.32 | 2.21 | 2.52 |
| Fixed Asset Turnover | 3.93 | 4.11 | 4.10 | 4.38 | 4.43 |
| Asset Turnover | 0.58 | 0.56 | 0.51 | 0.65 | 1.23 |
| Working Capital Turnover Ratio | 13.31 | -8.81 | -9.92 | 21.34 | 17.74 |
| Cash Conversion Cycle | 165.04 | 157.77 | 167.86 | 170.58 | 147.71 |
| Days of Sales Outstanding | 67.78 | 68.07 | 68.35 | 69.88 | 64.60 |
| Days of Inventory Outstanding | 146.89 | 152.98 | 157.31 | 165.00 | 144.97 |
| Days of Payables Outstanding | 49.63 | 63.28 | 57.80 | 64.30 | 61.86 |
| Operating Cycle | 214.67 | 221.05 | 225.66 | 234.88 | 209.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 29.49 | 12.30 | 19.62 | 24.00 | 24.86 |
| Free Cash Flow Per Share | 23.69 | 7.11 | 13.86 | 18.65 | 15.62 |
| Dividend Paid and CapEx Coverage Ratio | 1.06 | 0.47 | 0.77 | 0.99 | 0.91 |
| Capital Expenditure Coverage Ratio | 5.09 | 2.37 | 3.41 | 4.49 | 2.69 |
| Operating Cash Flow Coverage Ratio | 0.29 | 0.12 | 0.22 | 0.27 | 1.90 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.10 | 0.17 | 0.23 | 0.27 |
| Free Cash Flow Yield | 4.36% | 0.81% | 1.85% | 2.40% | 1.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 33.66 | 38.95 | 33.67 | 35.03 | 44.39 |
| Price-to-Sales (P/S) Ratio | 4.39 | 7.28 | 6.57 | 7.30 | 11.03 |
| Price-to-Book (P/B) Ratio | 7.59 | 10.97 | 9.31 | 19.88 | 26.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.92 | 122.99 | 53.95 | 41.59 | 64.44 |
| Price-to-Operating Cash Flow Ratio | 18.42 | 71.15 | 38.11 | 32.33 | 40.49 |
| Price-to-Earnings Growth (PEG) Ratio | -1.19 | 34.61 | 124.29 | -15.27 | 2.99 |
| Enterprise Value Multiple | 17.28 | 25.52 | 23.24 | 25.34 | 30.57 |
| Enterprise Value | 144.07B | 218.63B | 179.69B | 183.15B | 216.52B |
| EV to EBITDA | 17.28 | 25.52 | 23.24 | 25.34 | 30.57 |
| EV to Sales | 5.17 | 8.09 | 7.33 | 8.11 | 11.15 |
| EV to Free Cash Flow | 26.98 | 136.64 | 60.20 | 46.20 | 65.14 |
| EV to Operating Cash Flow | 21.68 | 79.04 | 42.52 | 35.92 | 40.93 |
| Tangible Book Value Per Share | -60.74 | -55.09 | -64.79 | -56.40 | 21.23 |
| Shareholders’ Equity Per Share | 71.54 | 79.78 | 80.31 | 39.02 | 38.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.41 | 0.21 | 0.21 | 0.23 | 0.23 |
| Revenue Per Share | 123.68 | 120.19 | 113.74 | 106.25 | 91.29 |
| Net Income Per Share | 16.13 | 22.46 | 22.21 | 22.15 | 22.67 |
| Tax Burden | 0.59 | 0.79 | 0.79 | 0.77 | 0.77 |
| Interest Burden | 0.88 | 0.87 | 0.90 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| SG&A to Revenue | 0.35 | 0.37 | 0.05 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.83 | 0.55 | 0.62 | 0.79 | 0.86 |
Currency in DKK
